» Articles » PMID: 8118945

Downregulation of Myocardial Beta-adrenergic Receptors. Receptor Subtype Selectivity

Overview
Journal Circ Res
Date 1994 Mar 1
PMID 8118945
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice.

Narita M, Hanada K, Kawamura Y, Ichikawa H, Sakai S, Yokono Y Hypertens Res. 2021; 44(10):1261-1273.

PMID: 34285375 DOI: 10.1038/s41440-021-00700-7.


S-Palmitoylation of a Novel Site in the β2-Adrenergic Receptor Associated with a Novel Intracellular Itinerary.

Adachi N, Hess D, McLaughlin P, Stamler J J Biol Chem. 2016; 291(38):20232-46.

PMID: 27481942 PMC: 5025705. DOI: 10.1074/jbc.M116.725762.


Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation.

Jensen B, OConnell T, Simpson P J Cardiovasc Pharmacol. 2013; 63(4):291-301.

PMID: 24145181 PMC: 3980029. DOI: 10.1097/FJC.0000000000000032.


Differential cardiotoxic/cardioprotective effects of beta-adrenergic receptor subtypes in myocytes and fibroblasts in doxorubicin cardiomyopathy.

Fajardo G, Zhao M, Powers J, Bernstein D J Mol Cell Cardiol. 2006; 40(3):375-83.

PMID: 16458323 PMC: 3140223. DOI: 10.1016/j.yjmcc.2005.12.004.


Laminin binding to beta1-integrins selectively alters beta1- and beta2-adrenoceptor signalling in cat atrial myocytes.

Wang Y, Samarel A, Lipsius S J Physiol. 2000; 527 Pt 1:3-9.

PMID: 10944166 PMC: 2270063. DOI: 10.1111/j.1469-7793.2000.t01-2-00003.x.